{"id":"https://openalex.org/W3213386299","doi":"https://doi.org/10.1182/blood-2021-145658","title":"Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease","display_name":"Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3213386299","doi":"https://doi.org/10.1182/blood-2021-145658","mag":"3213386299"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-145658","doi":"https://doi.org/10.1182/blood-2021-145658","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-145658","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103977070","display_name":"Mahir Khan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mahir Khan","raw_affiliation_strings":["Department of Medicine, University of Illinois at Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Illinois at Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068456972","display_name":"Jin Han","orcid":"https://orcid.org/0000-0003-0662-006X","observed_orcids":["https://orcid.org/0000-0003-0662-006X"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jin Han","raw_affiliation_strings":["Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030174386","display_name":"Santosh L. Saraf","orcid":"https://orcid.org/0000-0002-8584-4194","observed_orcids":["https://orcid.org/0000-0002-8584-4194"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Santosh L. Saraf","raw_affiliation_strings":["Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061639314","display_name":"Robert E. Molokie","orcid":"https://orcid.org/0000-0003-3623-7395","observed_orcids":["https://orcid.org/0000-0003-3623-7395"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert E. Molokie","raw_affiliation_strings":["University of Illinois at Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I39422238"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"2038","last_page":"2038"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.5098000168800354,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.5098000168800354,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.3041999936103821,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.1339000016450882,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.9430000185966492},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/opioid-reversal","display_name":"opioid reversal","score":0.9599999785423279},{"id":"https://openalex.org/keywords/respiratory-depression","display_name":"respiratory depression","score":0.8399999737739563},{"id":"https://openalex.org/keywords/patient-controlled-analgesia","display_name":"patient-controlled analgesia","score":0.8960000276565552},{"id":"https://openalex.org/keywords/capnography","display_name":"capnography","score":0.9559999704360962},{"id":"https://openalex.org/keywords/opioid-dosing","display_name":"opioid dosing","score":0.6340000033378601},{"id":"https://openalex.org/keywords/pain-relief","display_name":"analgesia","score":0.7509999871253967},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.7139999866485596},{"id":"https://openalex.org/keywords/opioid-poisoning","display_name":"opioid toxicity","score":0.5270000100135803},{"id":"https://openalex.org/keywords/hospital-policy-implementation","display_name":"hospital policy implementation","score":0.3499999940395355}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8844912052154541},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.8360868096351624},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.569797933101654},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5325924754142761},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5222437977790833},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4956129789352417},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4525638222694397},{"id":"https://openalex.org/C2779148768","wikidata":"https://www.wikidata.org/wiki/Q17154378","display_name":"Opioid overdose","level":5,"score":0.4415702521800995},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.43660420179367065},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.38887932896614075},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3384605348110199},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32900190353393555},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-145658","doi":"https://doi.org/10.1182/blood-2021-145658","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-145658","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4399456912","https://openalex.org/W4405043247","https://openalex.org/W3095983849","https://openalex.org/W2469726173","https://openalex.org/W2040877534","https://openalex.org/W2766042477","https://openalex.org/W2474108188","https://openalex.org/W2993144573","https://openalex.org/W2484292552","https://openalex.org/W2749349218"],"abstract_inverted_index":{"Abstract":[0],"Patients":[1],"with":[2,51,111,121,447,549,569,585,674],"sickle":[3,224,320,599],"cell":[4,225,321,600],"disease":[5],"(SCD)":[6],"are":[7,671],"known":[8,28],"to":[9,18,36,157,188,205,304,318,412,558,597,638,653],"require":[10,32],"increased":[11,659],"dosing":[12],"of":[13,41,61,74,81,96,131,160,196,209,231,273,308,327,336,350,359,384,396,405,421,442,453,489,502,524,530,533,581,591,609,631,644,655,702,722,737],"drugs":[14],"including":[15],"opioids":[16],"due":[17,637],"differences":[19],"in":[20,55,86,127,146,154,296,374,439,476,583,612,622,647,677],"renal":[21],"and":[22,67,176,193,227,252,276,343,366,381,418,495,545,697],"hepatic":[23],"metabolism.":[24],"While":[25],"it":[26,43],"is":[27,44,49,64,69,615],"that":[29,657,665],"SCD":[30,107,148,232,242,305,330,353,378,399,416,467,586,613,648,678,685],"patients":[31,155,220,233,243,316,331,354,379,400,417,430,468,508,584,614,649,686],"higher":[33,667],"opioid":[34,62,84,144,443,457,474,603,660,669,695],"doses":[35,254,259,294,339,362,532],"achieve":[37],"the":[38,79,94,128,158,213,222,229,274,280,297,319,387,440,464,477,577,598,607,629,666],"same":[39],"degree":[40],"analgesia,":[42],"not":[45,459,510,672],"clear":[46],"if":[47],"this":[48,75,132,135,634,709],"associated":[50,673],"a":[52,82,91,112,263,519,570],"similar":[53],"increase":[54],"drug":[56],"toxicities.":[57],"A":[58,199,528],"significant":[59,372,620],"risk":[60],"use":[63,95,153,191,376,423,580,611,624,630,646],"respiratory":[65],"depression,":[66],"naloxone":[68,142,152,190,210,293,375,422,438,455,472,534,559,571,582,610,623,645],"used":[70,204,285],"for":[71,105,114,143,164,288,456,473,521,692,708],"rapid":[72],"reversal":[73,145,475],"adverse":[76],"effect.":[77],"In":[78,134],"setting":[80],"nationwide":[83],"shortage":[85],"2018,":[87],"our":[88,139],"institution":[89],"established":[90],"policy":[92,626],"requiring":[93],"patient-controlled":[97],"analgesia":[98],"(PCA)":[99],"rather":[100],"than":[101],"intravenous":[102],"push":[103],"(IVP)":[104],"hospitalized":[106,147],"patients.":[108,149,306,679],"This":[109],"coincided":[110,548],"mandate":[113],"end":[115],"tidal":[116],"carbon":[117],"dioxide":[118],"(ETCO)":[119],"monitoring":[120],"PCA":[122],"use,":[123],"effectively":[124],"implementing":[125],"ETCO":[126,197],"routine":[129],"care":[130],"population.":[133,710],"study,":[136],"we":[137,247,268,284],"describe":[138],"experience":[140],"using":[141,237,694],"We":[150,218,409],"studied":[151,269],"admitted":[156,317,596],"University":[159],"Illinois":[161],"at":[162],"Chicago":[163],"two":[165,298,388],"24-month":[166],"time":[167,299,389],"periods":[168,236,390],"(July":[169],"31,":[170,174],"2015":[171,342],"-":[172,180],"July":[173,341,344],"2017":[175],"May":[177,181,364,367],"1,":[178,182],"2018":[179,365],"2020).":[183],"These":[184],"dates":[185],"were":[186,260,302,314,324,347,393,410,480,509,535],"chosen":[187],"compare":[189],"before":[192,380],"after":[194,382,625],"implementation":[195,383],"monitoring.":[198],"pharmacy":[200],"reporting":[201],"tool":[202],"was":[203,370,498,518,542,561,567,618],"identify":[206],"every":[207,594],"dose":[208,560],"administered":[211],"within":[212,262],"hospital":[214],"during":[215],"these":[216],"dates.":[217],"isolated":[219],"on":[221,718,733],"inpatient":[223],"service":[226,601],"compared":[228],"proportion":[230,608],"between":[234,340,363],"study":[235,575],"Fisher's":[238],"exact":[239],"test.":[240],"For":[241,265,386],"who":[244,332,355,401,431,469],"received":[245,333,356,402,437,471],"naloxone,":[246],"obtained":[248],"baseline":[249],"patient":[250,446,566,595],"characteristics":[251],"divided":[253],"into":[255],"episodes":[256,420,449,505],"when":[257,507,706],"multiple":[258,448],"given":[261,295,303,536],"day.":[264],"each":[266,436],"episode,":[267],"analgesic":[270],"regimens,":[271],"details":[272],"hospitalization,":[275],"laboratory":[277],"values.":[278],"Given":[279],"small":[281],"data":[282],"sample,":[283],"descriptive":[286],"statistics":[287],"analysis.":[289],"Among":[290,427,463],"931":[291,406],"total":[292,310],"periods,":[300],"35":[301,403],"Out":[307],"580":[309,397],"distinct":[311],"patients,":[312],"there":[313,392],"14":[315,394,503,525],"service.":[322],"There":[323,346,369,617],"5":[325],"out":[326,335,349,358,395,404,488,501,523],"279":[328],"(1.8%)":[329],"12":[334],"443":[337],"(2.7%)":[338],"2017.":[345],"10":[348,415],"309":[351],"(3.2%)":[352],"23":[357],"488":[360],"(4.7%)":[361],"2020.":[368],"no":[371,619],"difference":[373,621],"by":[377,424],"ETCO.":[385],"combined,":[391],"(2.4%)":[398],"(3.8%)":[407],"doses.":[408],"able":[411],"manually":[413],"confirm":[414],"17":[419],"chart":[425],"review.":[426],"these,":[428],"2":[429,531],"only":[432],"had":[433,450,491],"1":[434,562],"episode":[435,452],"absence":[441],"overdose.":[444],"One":[445,565],"an":[451,719,734],"receiving":[454,511],"overdose":[458],"involving":[460],"hospital-administered":[461],"medications.":[462],"remaining":[465],"8":[466,490],"appropriately":[470],"hospital,":[478],"100%":[479],"black":[481],"or":[482,724,739],"African":[483],"American":[484],"race.":[485],"Seven":[486],"(87.5%)":[487],"Hgb":[492],"SS":[493],"genotype,":[494],"male-to-female":[496],"ratio":[497],"1:1.":[499],"Six":[500],"(42.9%)":[504],"occurred":[506],"their":[512],"usual":[513],"pain":[514,604,693],"regimen.":[515],"Vaso-occlusive":[516],"crisis":[517],"diagnosis":[520],"13":[522],"(92.9%)":[526],"episodes.":[527],"median":[529],"per":[537],"episode.":[538],"Median":[539,553],"creatinine":[540],"clearance":[541],"20.85":[543],"mL/min,":[544],"several":[546],"cases":[547],"acute":[550],"kidney":[551],"injury.":[552],"sedation":[554],"scale":[555],"score":[556],"prior":[557],"(minimally":[563],"sedated).":[564],"treated":[568,691],"continuous":[572],"infusion.":[573],"Our":[574,662],"highlights":[576],"relatively":[578],"low":[579,642],"despite":[587],"generally":[588],"high":[589],"usage":[590],"opioids.":[592],"Nearly":[593],"utilizes":[602],"medications,":[605,696],"but":[606,633],"small.":[616],"changes":[627],"instituted":[628],"ETCO,":[632,684],"may":[635,650],"be":[636,651,690,700],"sample":[639],"size.":[640],"The":[641],"rates":[643],"related":[652],"mechanisms":[654],"hyperfiltration":[656],"necessitate":[658],"dosing.":[661],"results":[663],"suggest":[664],"observed":[668],"dosages":[670],"worsened":[675],"toxicities":[676],"With":[680],"techniques":[681],"such":[682],"as":[683],"can":[687],"more":[688],"safely":[689],"providers":[698],"should":[699],"mindful":[701],"pertinent":[703],"pharmacological":[704],"factors":[705],"caring":[707],"Disclosures":[711],"Saraf:":[712],"Pfizer:":[713],"Research":[714,727,742],"Funding;":[715,728],"Novartis:":[716],"Membership":[717,732],"entity's":[720,735],"Board":[721,736],"Directors":[723,738],"advisory":[725,740],"committees,":[726,741],"Global":[729],"Blood":[730],"Therapeutics:":[731],"Funding.":[743]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-11-22T00:00:00"}